ClassID:

94254

C07D213/86 - CPC Classification

Classification description:

Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms; Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals Hydrazides; Thio or imino analogues thereof

Sub-classes:
Recent Application in this class:
#1
20240180916
2024-06-06

Theramutein modultors

#2
20240124392
2024-04-18

ANTI-FUNGALS COMPOUNDS TARGETING THE SYNTHESIS OF FUNGAL SPHINGOLIPIDS

#3
20220394973
2022-12-15

Anti-fungals compounds targeting the synthesis of fungal sphingolipids

#4
20220370469
2022-11-24

Theramutein modulators

#5
20220362257
2022-11-17

Theramutein modulators

#6
20210015825
2021-01-21

Theramutein modulators

#7
20210009509
2021-01-14

HDAC inhibitor compounds and methods of treatment

#8
20210008077
2021-01-14

Theramutein modulators

#9
20200207705
2020-07-02

Anti-fungals compounds targeting the synthesis of fungal sphingolipids

#10
20200046718
2020-02-13

Theramutein modulators

#11
20190100490
2019-04-04

Multi-directional polydentate ligands for metal-organic hybrid structures

#12
20180222857
2018-08-09

Aryl sulfonohydrazides

#13
20180194718
2018-07-12

Neprilysin inhibitors

#14
20180042935
2018-02-15

Theramutein modulators

#15
20170369445
2017-12-28

α-ketoacylic isoniazid compounds, process for producing said compounds, use of the compounds in the treatment of tuberculosis

#16
20170327459
2017-11-16

Neprilysin inhibitors

#17
20170174619
2017-06-22

HDAC inhibitor compounds and methods of treatment

#18
20170015619
2017-01-19

Neprilysin inhibitors

#19
20160039750
2016-02-11

Bioavailable Diacylhydrazine Ligands for Modulating the Expression of Exogenous Genes via an Ecdysone Receptor Complex

#20
20150166510
2015-06-18

Method for producing 4-[5-(pyridin-4-yl)-1H-1,2,4-triazol-3-yl]pyridine-2-carbonitrile, and intermediate thereof

#21
20150141415
2015-05-21

Methionine Aminopeptidase Inhibitors for Treating Infectious Diseases

#22
20150133441
2015-05-14

Theramutein modulators

#23
20140357678
2014-12-04

Compounds having antibacterial activity, process for their preparation and pharmaceutical compositions comprising them

#24
20140045903
2014-02-13

Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex

#25
20130150415
2013-06-13

Rationally improved isoniazid and ethionamide derivatives and activity through selective isotopic substitution

#26
20130150358
2013-06-13

THERAMUTEIN MODULATORS

#27
20130040389
2013-02-14

Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex

#28
20130035487
2013-02-07

Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex

#29
20120065206
2012-03-15

Sulfonylhydrazide compounds for treating proliferative disorders

#30
20120046322
2012-02-23

Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex

#31
20110245262
2011-10-06

Compounds for treating proliferative disorders

#32
20110218220
2011-09-08

Rationally improved isoniazid and ethionamide derivatives and activity through selective isotopic substitution

#33
20110098476
2011-04-28

Process for preparing bis(thiohydrazide amides)

#34
20100240654
2010-09-23

HYDRAZIDE DERIVATIVES

#35
20090275070
2009-11-05

Compounds and Methods of Identifying, Synthesizing, Optimizing and Profiling Protein Modulators

#36
20090221547
2009-09-03

Immunosuppressant Compounds and Compositions

#37
20090018141
2009-01-15

Kinase inhibitors, compositions thereof, and methods of use therewith

#38
20080269262
2008-10-30

Therameutin modulators

#39
20080255134
2008-10-16

Cardiotonic Compounds With Inhibitory Activity Against Beta-Adrenergic Receptors And Phosphodiesterase

#40
20080132507
2008-06-05

Hydrazide Derivatives

#41
20080064741
2008-03-13

Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex

#42
20070259919
2007-11-08

2-substituted pyridines, processes for their preparation and their use for controlling harmful fungi

#43
20070197495
2007-08-23

ANTI-PARASITIC COMPOUNDS AND METHODS OF THEIR USE

#44
20060258740
2006-11-16

Diacylglycerol acyltransferase inhibitors

#45
20060020146
2006-01-26

Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex

#46
20050182103
2005-08-18

Substituted 2,3-diphenyl pyridines